Zydus Lifesciences, the Ahmedabad-based pharma giant, has started the intraday trade on Wednesday, March 19, on a positive note. This spurt in the share prices in the early session is a result of ...
Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...
Zydus Lifesciences Limited announced today it has received final approval from the US Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram. The medication ...
Zydus Lifesciences on Wednesday (February 26 ... vaccine as per WHO recommended composition,” the Ahmedabad-based drug major said in a statement. “Zydus’s Quadrivalent Inactivated Influenza ...
Zydus Lifesciences has entered exclusive negotiations ... following which the Ahmedabad-based pharma company will make a mandatory cash offer for the remaining shares, valuing the potential ...